FALSINI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 2.200
EU - Europa 1.036
AS - Asia 915
SA - Sud America 102
AF - Africa 22
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.291
Nazione #
US - Stati Uniti d'America 2.167
RU - Federazione Russa 408
SG - Singapore 227
CN - Cina 225
HK - Hong Kong 148
IT - Italia 138
IE - Irlanda 128
VN - Vietnam 127
PL - Polonia 105
SE - Svezia 89
BR - Brasile 79
KR - Corea 58
IN - India 46
FR - Francia 34
DE - Germania 32
GB - Regno Unito 30
FI - Finlandia 24
JO - Giordania 23
ES - Italia 20
CA - Canada 19
JP - Giappone 14
AR - Argentina 12
AU - Australia 11
ID - Indonesia 11
NL - Olanda 11
MX - Messico 10
TR - Turchia 7
IQ - Iraq 6
UA - Ucraina 6
BD - Bangladesh 5
BE - Belgio 4
EG - Egitto 4
EU - Europa 4
PK - Pakistan 4
SN - Senegal 4
CI - Costa d'Avorio 3
MA - Marocco 3
PE - Perù 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
EC - Ecuador 2
MY - Malesia 2
OM - Oman 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.291
Città #
Santa Clara 564
Ashburn 291
Fairfield 149
Chandler 141
Singapore 138
Dublin 128
Hong Kong 128
Warsaw 105
San Jose 81
Houston 74
Woodbridge 74
Seattle 67
Cambridge 62
Beijing 58
Wilmington 58
Seoul 55
Florence 47
Dong Ket 40
Ann Arbor 36
Mumbai 30
The Dalles 30
Princeton 29
Council Bluffs 28
Los Angeles 27
Ho Chi Minh City 25
Altamura 23
Lawrence 23
Clifton 22
Shanghai 21
Lauterbourg 20
New York 19
Hanoi 18
Barcelona 17
Boston 15
Helsinki 15
Buffalo 14
Moscow 14
Munich 14
Hefei 12
Dallas 11
Falls Church 11
Jakarta 11
Medford 11
Tokyo 11
Paris 10
San Diego 10
Gavirate 9
Melbourne 9
Guangzhou 8
Kent 8
Boardman 7
Cagliari 7
Chennai 7
Orem 7
Jacksonville 6
London 6
Redondo Beach 6
Basingstoke 5
Brooklyn 5
Da Nang 5
San Francisco 5
Shenzhen 5
Brussels 4
Chicago 4
City of London 4
Dakar 4
Jinan 4
Parma 4
Tianjin 4
Toronto 4
Abidjan 3
Atlanta 3
Can Tho 3
Curitiba 3
Haiphong 3
Norwalk 3
Pontassieve 3
Pune 3
Querétaro 3
Stockholm 3
São Paulo 3
Thái Nguyên 3
Amman 2
Amsterdam 2
Ankara 2
Baku 2
Biên Hòa 2
Buenos Aires 2
Camerino 2
Casablanca 2
Denver 2
Ferrara 2
Gustavo Adolfo Madero 2
Hillsboro 2
Icheon-si 2
Ipatinga 2
Islamabad 2
Johannesburg 2
Lappeenranta 2
Lima 2
Totale 2.996
Nome #
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 265
Design and synthesis of new adenosine receptor antagonists as neuroprotective agents 242
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 217
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 217
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 215
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 199
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 194
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 190
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 188
Development of novel pyridazinone-based adenosine receptor ligands 187
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 186
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists 174
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 169
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 169
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 168
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 166
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A 1 and A 2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 162
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 157
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 152
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2Aadenosine receptor antagonists/inverse agonists 138
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 132
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 131
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 129
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 129
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor 85
Totale 4.361
Categoria #
all - tutte 12.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 22 43
2021/2022185 6 12 27 4 6 8 7 13 6 17 30 49
2022/2023522 43 90 45 30 36 96 62 44 56 0 15 5
2023/2024219 5 20 23 10 7 53 9 48 10 18 10 6
2024/20251.347 30 151 71 152 440 213 14 86 62 40 53 35
2025/20261.250 175 177 64 130 163 61 175 70 103 101 31 0
Totale 4.361